Share on StockTwits
 

Varian Medical Systems (NYSE:VAR) Director Timothy E. Guertin sold 27,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $79.34, for a total value of $2,142,180.00. Following the transaction, the director now directly owns 48,683 shares in the company, valued at approximately $3,862,509. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Morgan Stanley reiterated an “underweight” rating on shares of Varian Medical Systems in a research note to investors on Thursday, January 23rd. They now have a $71.00 price target on the stock. Separately, analysts at Brean Capital raised their price target on shares of Varian Medical Systems from $80.00 to $95.00 in a research note to investors on Thursday, January 23rd. They now have a “buy” rating on the stock. Finally, analysts at Cantor Fitzgerald upgraded shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research note to investors on Thursday, January 23rd. They now have a $93.00 price target on the stock, up previously from $76.00. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $82.80.

Varian Medical Systems (NYSE:VAR) traded up 0.09% during mid-day trading on Wednesday, hitting $78.44. The stock had a trading volume of 389,511 shares. Varian Medical Systems has a 52-week low of $63.10 and a 52-week high of $84.24. The stock’s 50-day moving average is $79.54 and its 200-day moving average is $75.75. The company has a market cap of $8.123 billion and a price-to-earnings ratio of 19.43.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The company had revenue of $712.00 million for the quarter, compared to the consensus estimate of $718.23 million. Analysts expect that Varian Medical Systems will post $4.34 EPS for the current fiscal year.

Varian Medical Systems, Inc is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (NYSE:VAR), stereotactic radiosurgery (SRS) and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.